Xilio Therapeutics, Inc. (XLO)
8.57
+0.22
(+2.63%)
USD |
NASDAQ |
Apr 17, 16:00
8.29
-0.28
(-3.27%)
After-Hours: 20:00
Xilio Therapeutics Research and Development Expense (Quarterly) : 18.12M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Johnson & Johnson | 3.527B |
| Merck & Co., Inc. | 2.499B |
| Pfizer Inc. | 3.133B |
| Verastem, Inc. | 31.68M |
| Sensei Biotherapeutics, Inc. | 2.536M |